Cryoablation yields 81.1% clinical success and durable PFS for extra-abdominal desmoid tumors

Cryoablation for extra-abdominal desmoid tumors showed 81.1% clinical success, 67.4% 2-year progression-free survival (95% CI 46.5-81.7%), and 5.3% major adverse events in a 38-patient retrospective study.

• Repeat cryoablation was performed in 26.3% of patients due to radiologic progression.
• Volumetric and mRECIST response classifications showed almost-perfect agreement (κ = 0.895).
• 1-year progression-free survival was 76.5% (95% CI 58.2–87.6%).

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.